TY - JOUR
T1 - Intradermal-Stress-Lymphoscintigraphy in Early Detection and Clinical Management of Secondary Lymphedema: A Pictorial Essay
AU - Tartaglione, Girolamo
AU - Visconti, Giuseppe
AU - Bartoletti, Roberto
AU - Gentileschi, Stefano
AU - Ieria, Francesco Pio
AU - Colletti, Patrick M.
AU - Rubello, Domenico
AU - Salgarello, Marzia
PY - 2019
Y1 - 2019
N2 - Stress-lymphoscintigraphy evaluates the effects of exercise on lymph drainage. Results may predict outcomes of complex physical therapy as a first-line lymphedema treatment. Microsurgical approaches are best in patients with lymphangectasia or dermal backflow. Lymphatic pathway mapping helps plan lympho-venous anastomoses. For improved lymphatic visualization, we suggest a scan at rest, after a quick exercise (stepping or weight lifting for 2 min) and delayed scanning after prolonged symptom limited exercise (walking or hand squeezing for 30-40 min). In advanced lymphedema, identification of lymph pathways and residual regional lymph nodes might be difficult. In these patients, lymph node transplant is suggested.
AB - Stress-lymphoscintigraphy evaluates the effects of exercise on lymph drainage. Results may predict outcomes of complex physical therapy as a first-line lymphedema treatment. Microsurgical approaches are best in patients with lymphangectasia or dermal backflow. Lymphatic pathway mapping helps plan lympho-venous anastomoses. For improved lymphatic visualization, we suggest a scan at rest, after a quick exercise (stepping or weight lifting for 2 min) and delayed scanning after prolonged symptom limited exercise (walking or hand squeezing for 30-40 min). In advanced lymphedema, identification of lymph pathways and residual regional lymph nodes might be difficult. In these patients, lymph node transplant is suggested.
KW - early diagnosis
KW - secondary limb lymphedema
KW - stress lymphoscintigraphy
KW - early diagnosis
KW - secondary limb lymphedema
KW - stress lymphoscintigraphy
UR - http://hdl.handle.net/10807/142016
UR - http://journals.lww.com/nuclearmed/pages/default.aspx
U2 - 10.1097/RLU.0000000000002560
DO - 10.1097/RLU.0000000000002560
M3 - Article
SN - 0363-9762
VL - 44
SP - 669
EP - 673
JO - Clinical Nuclear Medicine
JF - Clinical Nuclear Medicine
ER -